Fish oil sits comfortably on the shelf of almost every health-conscious household. It has been recommended by doctors, praised by nutritionists, and marketed as one of the best things you can do for your brain. For most people, that reputation has seemed well earned. But new research is now asking us to look more carefully at that assumption, because for a specific group of people, the story may be far more complicated than we thought.
A study published in the journal Cell Reports, led by researchers at the Medical University of South Carolina in collaboration with Cold Spring Harbor Laboratory, has found that EPA, one of the two primary omega-3 fatty acids found in fish oil, may actually interfere with the brain’s ability to repair itself after repeated mild head injuries. The finding does not overturn everything we know about omega-3s. But it does introduce an important and previously overlooked nuance that anyone taking fish oil supplements should be aware of.
What Fish Oil Actually Contains
Before getting into what the research found, it helps to understand what fish oil is made of. When we talk about omega-3 fatty acids in fish oil, there are two key players,
• EPA (eicosapentaenoic acid)
• DHA (docosahexaenoic acid).
Most fish oil supplements contain both, and the two are often discussed interchangeably as though they behave in identical ways in the body.
They do not, and that distinction turns out to matter enormously here.
DHA is the omega-3 that makes up a significant portion of the brain’s structural fat. It is embedded in cell membranes and plays a direct role in maintaining neuronal function. The evidence for DHA’s protective role in the brain is well established and, importantly, the new research does not challenge it.
EPA is different. It is better known for its anti-inflammatory effects, particularly in cardiovascular health. It does have effects on the brain too, but what this research reveals are that under certain conditions, those effects may work against recovery rather than for it.
What the Study Found
The research team, led by neuroscientist Onder Albayram at MUSC, wanted to understand how long-term fish oil supplementation actually affects the brain’s recovery processes after repeated mild traumatic brain injuries, the kind accumulated over time through contact sports, military service, or recurrent falls.
They took a methodical, multi layered approach. First, they used mouse models subjected to repeated mild head impacts, examining how a fish oil enriched diet influenced the brain’s response during and after injury, specifically focusing on blood vessel stability and healing signals. What they found in the initial post injury period looked broadly normal. Recovery appeared to be proceeding as expected. But when they looked months later, a very different picture began to emerge.
According to the findings, in mouse brains where EPA levels were elevated, the repair of tiny blood vessels in the brain faltered significantly over time. EPA appeared to redirect the brain’s recovery away from rebuilding those damaged vessels, rather than supporting it.
The team then took their investigation to human biology, examining human brain microvascular endothelial cells. the specialized cells that form the barrier between the brain and the bloodstream. These cells are critical to what is known as the blood brain barrier, which protects the brain and regulates what enters it. The results showed that EPA, but not DHA, was associated with reduced repair function in these cells, consistent with what had been observed in the animal studies.
Finally, to connect these findings to real human disease, researchers analyzed postmortem brain tissue from people who had been confirmed cases of chronic traumatic encephalopathy, CTE, individuals with a documented history of repeated brain injuries. The patterns they found there aligned with what the laboratory work had suggested.
Why EPA May Be Working Against Recovery
To understand why this happens, it helps to think about what the brain needs after an injury.
When the brain sustains a mild traumatic impact, one of its most urgent priorities is repairing the small blood vessels that have been disrupted. These vessels are the brain’s supply chain, they deliver oxygen, remove waste, and carry the cellular signals that drive healing. Blood vessel integrity is not a minor housekeeping issue; it is fundamental to whether the brain actually recovers.
What this study suggests is that EPA reprograms how cerebrovascular cells manage their energy and repair priorities. In simpler terms, EPA appears to change how these cells use energy, shifting them away from repair rather than supporting it. Rather than supporting the rebuilding of damaged vessel walls, elevated EPA appears to shift cellular metabolism in a way that weakens endothelial repair function and disrupts the healing signals the brain depends on after injury. Over repeated impacts, this disruption compounds, and the long-term consequence appears to be worsening rather than resolution.
Importantly, the researchers also found protein buildup consistent with cognitive decline in the EPA-exposed tissue, the kind of pathological changes associated with CTE progression.
As lead researcher Albayram put it, this paper opens a new conversation about precision nutrition in neuroscience, and gives the field a framework to ask better, more testable questions.
Who Does This Actually Apply To?
This is where context matters enormously, and it would be a mistake to read these findings as a reason for everyone to abandon their fish oil supplements altogether.
The research is specifically focused on people with a history of repeated mild traumatic brain injuries. That includes rugby players, footballers, boxers, American football players, military veterans exposed to blast injuries, and older adults with a history of recurrent falls. In practical terms, this could be someone who has had multiple concussions over time or years of repeated head impacts, even if each one seemed mild at the time. For these individuals, the findings are clinically meaningful and worth a serious conversation with their doctor or pharmacist.
For the general population taking fish oil for cardiovascular health, mood support, or general cognitive maintenance, the research does not suggest harm.
Neurologists commenting on the findings have been clear that this does not prove fish oil causes brain damage in the general population, and that people should not abruptly stop anything recommended by their doctor.
The key phrase the researchers themselves use is context dependent vulnerability. Fish oil’s impact on the brain appears to depend heavily on individual circumstances and injury history, and that is a concept that should inform how we think about supplementation more broadly
What About DHA?
This distinction deserves particular attention because it has real practical implications.
According to the study findings, DHA did not show the same harmful effects on endothelial repair function that EPA did. The two fatty acids, though packaged together in most standard fish oil supplements, appear to behave differently at the cellular level when the brain has been repeatedly injured.
There is already a body of evidence supporting DHA’s role in brain health, particularly in relation to neuronal membrane structure and neuroprotection. Whether DHA dominant or DHA only formulations might offer a safer alternative for those with head injury histories is an area the researchers are now exploring. Future work from the team aims to track how EPA is transported and distributed in the body, which may open the door to more refined supplementation strategies.
The Broader Lesson Here
What this research really underscores is something that pharmacists have long understood but that supplement marketing rarely communicates: supplements are not universally beneficial in all contexts for all people. The same compound that supports one biological process can interfere with another under different circumstances.
Fish oil is not suddenly dangerous. For the vast majority of people, it remains a well evidenced supplement with genuine benefits. But for anyone with a history of repeated head injuries, athletes, veterans, or individuals who have experienced multiple concussions, this is a conversation worth having with a healthcare professional before continuing long-term EPA supplementation. In some cases, it may even be worth reviewing the type and balance of omega-3s being used, rather than assuming all fish oil products work the same way.
The brain is not a simple system, and neither is what we put into it.
FAQs
Q1. Is this study saying fish oil is bad for the brain?
Not for most people, no, the study is specifically focused on a context-dependent risk, meaning the concern applies to people who experience repeated mild head injuries, not the general population. For the vast majority of adults taking fish oil for heart health, mood, or general brain support, the existing evidence for its benefits still stands. The researchers themselves were clear that this is not a call for the public to abandon fish oil supplements.
Q2. What exactly is EPA and how is it different from DHA?
Both EPA and DHA are omega-3 fatty acids found in fish oil, and most standard supplements contain both. DHA is more structurally embedded in the brain; it builds nerve cell membranes and tends to remain fixed in brain tissue. EPA, by contrast, is less anchored in those membranes and is more readily drawn into injury-related metabolic processes. That difference in behavior appears to be at the heart of this finding.
Q3. Why does EPA seem to cause problems specifically after repeated head injuries?
Under normal conditions, EPA does not appear to act as a toxin. The problem emerges when brain cells are in a state of injury-related metabolic stress. In those conditions, EPA appears to be drawn into the recovery process in a way that weakens blood vessel repair rather than supporting it, disrupting the very healing mechanisms the brain depends on after repeated impacts.
Q4. What did the study actually find in human brain tissue?
Researchers examined postmortem brain tissue from individuals with confirmed CTE, chronic traumatic encephalopathy, who had a history of repeated brain injuries. They found evidence of disrupted fatty acid balance and broad changes affecting the vascular and metabolic pathways in the brain, consistent with patterns seen in the animal and cell studies. The CTE tissue also showed around 150% more EPA and DHA than control tissue, alongside an 80% rise in a fat linked to inflammation.
Q5. Does DHA carry the same risk?
Based on the current evidence, no. In both the mouse models and the human endothelial cell experiments, DHA did not show the same harmful effects on brain vessel repair that EPA did. This is a meaningful distinction, and researchers are now exploring whether DHA-dominant formulations might be more appropriate for people with head injury histories.
Q6. Who should be most cautious about long-term EPA supplementation?
The groups most relevant to these findings are those with a history of repeated mild traumatic brain injuries, contact sport athletes such as rugby, football, and boxing players, military veterans exposed to blast injuries, and older adults with a history of recurrent falls or multiple concussions. If you fall into one of these categories and are taking fish oil regularly, it is worth raising this research with your doctor or pharmacist before continuing.
Q7. Should I stop taking fish oil straight away if I have had concussions in the past?
Please do not make that decision based on a single study without speaking to a healthcare professional first. This research is described by its own authors as a starting point, important, but not yet definitive enough to translate into blanket clinical guidance. What it does provide is a solid reason to have a more tailored conversation about your supplement use in the context of your personal health history.
Q8. Will future research change these recommendations?
Quite possibly. The research team’s next steps involve tracking exactly how EPA is absorbed, transported, and distributed in the body, which may allow for more refined guidance on dosing, timing, or formulation. The broader implication of this work is that we are moving towards an era of precision nutrition in neuroscience, where supplement recommendations will increasingly need to account for individual context rather than applying one rule to everyone.
Q9. Want to Make Smarter Decisions About Your Brain Health?
Most supplement advice is written as though one rule fits everyone. This research is a reminder that it does not, and that understanding the nuance behind
Call to Action
What you take, and when, can make a genuine difference.
At PharmaHealths, we focus on evidence that matters, translating complex medical research into clear, accurate insights you can actually use. Whether you’re navigating supplements, medication decisions, or emerging findings in metabolic and brain health, our content is designed to help you make sense of it with confidence.
Explore our full library of articles, and if this piece made you reconsider something on your supplement shelf, share it with someone who might benefit from it too.
Because better decisions start with better understanding.
Disclaimer
Reviewed in accordance with PharmaHealths editorial standards. This content is for informational purposes only and does not constitute medical advice.
References
• Karakaya E, Berber B, Eskiocak O, Edwards J, Barker RB, Jamil S, Li W, Abdul Y, Ericsson M, Stein T, McKee A, Ergul A, Beyaz S, Albayram O. Eicosapentaenoic acid reprograms cerebrovascular metabolism and impairs repair after brain injury, with relevance to chronic traumatic encephalopathy. Cell Reports. 2026; 117135. DOI: 10.1016/j.celrep.2026.117135
• Medical University of South Carolina. MUSC-led study challenges widespread belief about fish oil’s effects on brain. EurekAlert! Published March 25, 2026. Available at: eurekalert.org/news-releases/1123156
• Medical University of South Carolina. Fish oil may be hurting your brain, new study finds. ScienceDaily. Published April 26, 2026. Available at: sciencedaily.com/releases/